[Paris, France – September 2020]
Plantibodies is proud to announce its acceptance into the Pépinière 27 incubator in the heart of Paris. In parallel, the company has been awarded a €30,000 PIA (Paris Innovation Amorçage) grant to support its early-stage development and launch its first proof-of-concept experiments.
The grant will allow Plantibodies to accelerate its R&D efforts and begin validating its unique plant-based bioproduction platform — designed to manufacture biologics faster, cheaper, safer, in large quantities.
“Joining Pépinière 27 gives us access to a vibrant ecosystem of startups and support,” says Pierre Bauër, co-founder and CEO of Plantibodies. “Combined with the PIA funding, it’s a crucial first step to demonstrate the power of our approach.”
Pépinière 27 is known for supporting startups at the seed stage. This environment positions Plantibodies ideally for rapid growth and early scientific milestones.